These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Evaluation of the efficacy and safety of lanreotide in combination with targeted therapies in patients with neuroendocrine tumours in clinical practice: a retrospective cross-sectional analysis. Capdevila J; Sevilla I; Alonso V; Antón Aparicio L; Jiménez Fonseca P; Grande E; Reina JJ; Manzano JL; Alonso Lájara JD; Barriuso J; Castellano D; Medina J; López C; Segura Á; Carrera S; Crespo G; Fuster J; Munarriz J; García Alfonso P BMC Cancer; 2015 Jul; 15():495. PubMed ID: 26138480 [TBL] [Abstract][Full Text] [Related]
23. Prospective evaluation of the long-term outcomes after deep small-bowel spiral enteroscopy in patients with obscure GI bleeding. Williamson JB; Judah JR; Gaidos JK; Collins DP; Wagh MS; Chauhan SS; Zoeb S; Buscaglia JM; Yan H; Hou W; Draganov PV Gastrointest Endosc; 2012 Oct; 76(4):771-8. PubMed ID: 22771101 [TBL] [Abstract][Full Text] [Related]
24. Capsule endoscopy and single-balloon enteroscopy in small bowel diseases: Competing or complementary? Ma JJ; Wang Y; Xu XM; Su JW; Jiang WY; Jiang JX; Lin L; Zhang DQ; Ding J; Chen L; Jiang T; Xu YH; Tao G; Zhang HJ World J Gastroenterol; 2016 Dec; 22(48):10625-10630. PubMed ID: 28082815 [TBL] [Abstract][Full Text] [Related]
25. Prospective, randomized, multicenter trial on the antiproliferative effect of lanreotide, interferon alfa, and their combination for therapy of metastatic neuroendocrine gastroenteropancreatic tumors--the International Lanreotide and Interferon Alfa Study Group. Faiss S; Pape UF; Böhmig M; Dörffel Y; Mansmann U; Golder W; Riecken EO; Wiedenmann B; J Clin Oncol; 2003 Jul; 21(14):2689-96. PubMed ID: 12860945 [TBL] [Abstract][Full Text] [Related]
27. Diagnostic yield of capsule endoscopy vs. double-balloon endoscopy for patients who have undergone total enteroscopy with obscure gastrointestinal bleeding. Shishido T; Oka S; Tanaka S; Aoyama T; Watari I; Imagawa H; Yoshida S; Chayama K Hepatogastroenterology; 2012 Jun; 59(116):955-9. PubMed ID: 22580642 [TBL] [Abstract][Full Text] [Related]
28. The role of capsule endoscopy combined with double-balloon enteroscopy in diagnosis of small bowel diseases. Li XB; Ge ZZ; Dai J; Gao YJ; Liu WZ; Hu YB; Xiao SD Chin Med J (Engl); 2007 Jan; 120(1):30-5. PubMed ID: 17254484 [TBL] [Abstract][Full Text] [Related]
29. Symptomatic treatment with lanreotide microparticles in inoperable bowel obstruction resulting from peritoneal carcinomatosis: a randomized, double-blind, placebo-controlled phase III study. Mariani P; Blumberg J; Landau A; Lebrun-Jezekova D; Botton E; Beatrix O; Mayeur D; Herve R; Maisonobe P; Chauvenet L J Clin Oncol; 2012 Dec; 30(35):4337-43. PubMed ID: 23109694 [TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics of the somatostatin analog lanreotide in patients with severe chronic renal insufficiency. Barbanoj M; Antonijoan R; Morte A; Grinyó JM; Solà R; Vallès J; Peraire C; Cordero JA; Muñoz A; Jané F; Obach R Clin Pharmacol Ther; 1999 Nov; 66(5):485-91. PubMed ID: 10579475 [TBL] [Abstract][Full Text] [Related]
31. Small bowel capsule endoscopy in obscure gastrointestinal bleeding: normalcy is not reassuring. Cúrdia Gonçalves T; Dias de Castro F; Moreira MJ; Rosa B; Cotter J Eur J Gastroenterol Hepatol; 2014 Aug; 26(8):927-32. PubMed ID: 24922357 [TBL] [Abstract][Full Text] [Related]
32. Long-term outcome after argon plasma coagulation of small-bowel lesions using double-balloon enteroscopy in patients with mid-gastrointestinal bleeding. May A; Friesing-Sosnik T; Manner H; Pohl J; Ell C Endoscopy; 2011 Sep; 43(9):759-65. PubMed ID: 21544778 [TBL] [Abstract][Full Text] [Related]
33. Clinical impact of capsule endoscopy on further strategy and long-term clinical outcome in patients with obscure bleeding. Hindryckx P; Botelberge T; De Vos M; De Looze D Gastrointest Endosc; 2008 Jul; 68(1):98-104. PubMed ID: 18291382 [TBL] [Abstract][Full Text] [Related]
34. Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomised, phase 3 trial. Gadelha MR; Bronstein MD; Brue T; Coculescu M; Fleseriu M; Guitelman M; Pronin V; Raverot G; Shimon I; Lievre KK; Fleck J; Aout M; Pedroncelli AM; Colao A; Lancet Diabetes Endocrinol; 2014 Nov; 2(11):875-84. PubMed ID: 25260838 [TBL] [Abstract][Full Text] [Related]
35. Clinical outcome after enteroscopy for small bowel angioectasia bleeding: A Korean Associateion for the Study of Intestinal Disease (KASID) multiceter study. Jeon SR; Byeon JS; Jang HJ; Park SJ; Im JP; Kim ER; Koo JS; Ko BM; Chang DK; Kim JO; Park SY; J Gastroenterol Hepatol; 2017 Feb; 32(2):388-394. PubMed ID: 27356264 [TBL] [Abstract][Full Text] [Related]
36. Clinical usefulness of the endoscopic video capsule as the initial intestinal investigation in patients with obscure digestive bleeding: validation of a diagnostic strategy based on the patient outcome after 12 months. Delvaux M; Fassler I; Gay G Endoscopy; 2004 Dec; 36(12):1067-73. PubMed ID: 15578296 [TBL] [Abstract][Full Text] [Related]
37. One-year follow-up of patients with acromegaly treated with fixed or titrated doses of lanreotide Autogel. Caron P; Bex M; Cullen DR; Feldt-Rasmussen U; Pico Alfonso AM; Pynka S; Racz K; Schopohl J; Tabarin A; Valimaki MJ; Clin Endocrinol (Oxf); 2004 Jun; 60(6):734-40. PubMed ID: 15163338 [TBL] [Abstract][Full Text] [Related]
38. Long-acting somatostatin analogues provide significant beneficial effect in patients with refractory small bowel angiodysplasia: Results from a proof of concept open label mono-centre trial. Holleran G; Hall B; Breslin N; McNamara D United European Gastroenterol J; 2016 Feb; 4(1):70-6. PubMed ID: 26966525 [TBL] [Abstract][Full Text] [Related]
39. The use of small-bowel capsule endoscopy in iron-deficiency anemia alone; be aware of the young anemic patient. Koulaouzidis A; Yung DE; Lam JH; Smirnidis A; Douglas S; Plevris JN Scand J Gastroenterol; 2012 Sep; 47(8-9):1094-100. PubMed ID: 22852553 [TBL] [Abstract][Full Text] [Related]
40. Hepatic Cyst Infection During Use of the Somatostatin Analog Lanreotide in Autosomal Dominant Polycystic Kidney Disease: An Interim Analysis of the Randomized Open-Label Multicenter DIPAK-1 Study. Lantinga MA; D'Agnolo HM; Casteleijn NF; de Fijter JW; Meijer E; Messchendorp AL; Peters DJ; Salih M; Spithoven EM; Soonawala D; Visser FW; Wetzels JF; Zietse R; Drenth JP; Gansevoort RT; Drug Saf; 2017 Feb; 40(2):153-167. PubMed ID: 27995519 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]